| March 2013 | Halder | Industrials and Capital Goods | FERBER & CO. advised Halder on the sale of its shares in Alukon GmbH & Co. KG to Hörmann Group. |  |
|
| Closing is pending | Capiton and Alphapet Ventures | Consumer Goods and Retail | FERBER & CO. advised Capiton and Alphapet Ventures on the realignment of the shareholder base as part of the combination of Alphapet Ventures and Healthfood 24 (Wolfsblut) in the premium pet food segment. |  |
| Closing is pending | Alphapet Ventures | Consumer Goods and Retail | FERBER & CO. advised Alphapet Ventures to secure funding for its acquisition of Healthfood24 (Wolfsblut) through equity financing. | |
| Closing is pending | Dermapharm AG | Healthcare | FERBER & CO. advised Dermapharm on the acquisition of Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA. |  |
| July 2019 | Dermapharm AG | Healthcare | FERBER & CO. advised Dermapharm AG on the acquisition of 70% of the shares in Fitvia GmbH. | |
| February 2019 | Advent International | Healthcare | FERBER & CO. advised Advent International on the acquisition of Lavorel Medicare and Bonitas. | |
| January 2019 | Zur Rose/DocMorris | Healthcare | FERBER & CO. advised Zur Rose Group and DocMorris on the acquisition of medpex. | |
| January 2019 | Dermapharm AG | Healthcare | FERBER & CO. advised Dermapharm AG on the acquisition of Euromed from Riverside. | |
| January 2019 | Point Rouge | Healthcare | FERBER & CO. advised Point Rouge on the acquisition of ascopharm from Pagoda and Adiuva Capital. | |
| December 2018 | Katjes International | Consumer Goods and Retail | FERBER & CO. advised Katjes International on the sale of its minority ownership stake in Halloren Schokoladenfabrik AG to Charlie Investors S.à.r.l. | |
| November 2018 | Aenova | Healthcare | FERBER & CO. advised Aenova, a portfolio company of BC Partners, on the sale of 100% of the shares in Euro Vital Pharma to Capiton and the management. | |
